gut.bmj21h
Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B
Dr G Fattovich, Servizio Autonomo Clinicizzato di Gastroenterologia, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, Università di Verona, Via delle Menegone 10, 37134 Verona, Italy ...
gut.bmj1d
Endoscopic full-thickness plication for the treatment of PPI-dependent GERD: results from a randomised, sham controlled trial
Background The majority of endoscopic antireflux procedures for GERD are cumbersome to use and randomised long-term data are sparse. We conducted such a trial to determine the efficacy and safety of a ...
gut.bmj1d
Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome
Correspondence to Dr G Nicholas Verne, Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112-2699, USA; gverne{at}tulane.edu Background More effective treatments are ...
gut.bmj1d
Accuracy of screening for gastric cancer using serum pepsinogen concentrations
Professor M A Fujino, First Department of Medicine, Yamanashi Medical University, 1110 Shimokato, Tamaho-cho, Nakakoma-gun, Yamanashi 409-38, Japan. BACKGROUND/AIMS The characteristics of pepsinogen ...
gut.bmj2d
First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin
The Membrane Transport Laboratory, Cancer and Cell Biology Division, The Queensland Institute of Medical Research, Brisbane, Queensland, Australia Correspondence to: Dr V N Subramaniam The Membrane ...
gut.bmj2d
The epidemiology of hepatitis C in a UK health regional population of 5.12 million
BACKGROUND The epidemiology and natural history of hepatitis C virus (HCV) infection in the UK are uncertain. Previous reports are from small or selected populations such as blood donors or tertiary ...
gut.bmj2d
Early Crohn disease: a proposed definition for use in disease-modification trials
Crohn disease is a chronic condition characterised by intestinal inflammation and progressive bowel damage associated with impaired functioning. In rheumatoid arthritis, which shares some common ...
gut.bmj2d
Intestinal ganglioneuromatosis and multiple endocrine neoplasia type 2B: implications for treatment
Dr V V Smith, Histopathology, Camelia Botnar Laboratories, Great Ormond Street Hospital, Great Ormond Street, London WC1N 3JH, UK. Three infants, who presented with intestinal obstruction due to ...
gut.bmj3d
Pain in chronic pancreatitis: the role of neuropathic pain mechanisms
1 Mech-Sense, Department of Gastroenterology, Aalborg University Hospital, Aalborg, Denmark 2 Center for Sensory-Motor Interactions, Department of Health Science and Technology, Aalborg University, ...
gut.bmj3d
Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis
11 Liver Unit, St James's University Hospital, Leeds, UK Non-alcoholic steatohepatitis (NASH) is an increasing cause of liver disease necessitating liver transplantation. In patients with advanced ...
gut.bmj3d
Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease
Professor J P Galmiche, Centre de Recherche en Nutrition Humaine, CRI INSERM 95-08, CHU, Hôtel Dieu, Place A Ricordeau, 44035 Nantes cedex 01, France. Email:galmiche{at}easynet.fr BACKGROUND/AIM ...
gut.bmj4d
Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents
Objective Patients with renal failure suffer from symptoms caused by uraemic toxins, possibly of gut microbial origin, as deduced from studies in animals. The aim of the study is to characterise ...